ICG Silver & Gold Ltd. announced a new high-grade gold zone at its Tuscarora District project in Nevada, highlighted by a 24.3-meter intercept grading 10.14 g/t gold, including a 4.6-meter section at 51.84 g/t gold. This discovery is integrated into a 3D geological model combining over 40,000 meters of historical and recent drilling data, enhancing understanding of the district-scale mineralization. The company plans to release its inaugural mineral resource estimate for the district in Q1 2027, with further drill results pending. This advancement supports systematic exploration and potential future development of the project.
ICG Silver & Gold's new high-grade gold discovery in Nevada is presented here alongside Pluang's Basic Materials sector data for context. For readers following this sector, as of Oct 06, 2026 14:12 WIB, 22 out of 38 US stocks rose while 16 fell. Notably, Air Products & Chemicals, Inc. (APD) gained 0.77% to USD 279.71 with a typical hold time of 60 days, contrasting with Teck Resources (TECK) and Aspen Aerogels Inc (ASPN), which fell 0.91% and 0.79% to USD 67.94 and USD 5.64 respectively, held typically for 11 and 13 days on Pluang.
Ethereum (ETH) maintained stability above $2,700, marking its first weekly close above this level in nine months, signaling renewed bullish sentiment. Treasury firm BitMine expanded its Ethereum holdings by 15,112 ETH, now controlling about 4.9% of t...
Bitcoin options markets have shifted toward a bullish stance, with one-week 25-delta call options now more in demand than puts, indicating traders expect price gains. This shift, first seen in August 2026, shows calls making up about 61.4% of open in...
Binance experienced a net outflow of approximately 40,000 Bitcoin over a 15-day period, reducing its reserves from 704,800 BTC to 663,100 BTC. The weekly net outflow hit 23,100 BTC, the highest since June 2023, with a daily peak of 14,300 BTC on Octo...
Nebius Group N.V. is rated a buy due to its strategic partnership with Palantir, which positions Nebius as the preferred sovereign infrastructure provider for Palantir's enterprise AI solutions targeting regulated industries. This collaboration allow...
Poolbeg Pharma has obtained a South Korean patent for POLB 001, a treatment designed to prevent cytokine release syndrome (CRS), a serious side effect of cancer immunotherapy. The patent covers the use of p38 MAP kinase inhibitors to prevent CRS and ...
